Search Results for "lovastatin"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for lovastatin. Results 1 to 4 of 4 total matches.

Table 3: Some Drug Interactions with DAAs for HCV Infection (online only)

   
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024  (Issue 1714)
Not recommended Efavirenz Decreased DAA serum concentrations Not recommended Atorvastatin, lovastatin ...
View Table 3: Some Drug Interactions with DAAs for HCV Infection
Med Lett Drugs Ther. 2024 Oct 28;66(1714):e175   doi:10.58347/tml.2024.1714f |  Show IntroductionHide Introduction

Comparison Table: Some Lipid-Lowering Drugs (online only)

   
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022  (Issue 1659)
and lovastatin are metabolized by CYP3A4; concurrent use of strong CYP3A4 inhibitors7 can increase their serum ...
View the Comparison Table: Some Lipid-Lowering Drugs
Med Lett Drugs Ther. 2022 Sep 19;64(1659):e152-6 |  Show IntroductionHide Introduction

Lipid-Lowering Drugs

   
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022  (Issue 1659)
can be precipitated by drug interactions. Simvastatin and lovastatin undergo extensive first-pass ...
Cholesterol management guidelines from the American College of Cardiology/American Heart Association Task Force were last published in 2019.
Med Lett Drugs Ther. 2022 Sep 19;64(1659):145-52 |  Show IntroductionHide Introduction

Drugs for Hepatitis C Virus Infection

   
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024  (Issue 1714)
, atorvastatin, lovastatin, simvastatin, or high-dose cyclosporine (>100 mg/day) is not recommended.10 ...
About 2.5 million persons in the US had hepatitis C between 2017 and 2020. Guidelines from the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) on management of hepatitis C virus (HCV) infection were updated in 2023.
Med Lett Drugs Ther. 2024 Oct 28;66(1714):169-74   doi:10.58347/tml.2024.1714a |  Show IntroductionHide Introduction